These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Soluble epoxide hydrolase inhibitors and heart failure. Qiu H; Li N; Liu JY; Harris TR; Hammock BD; Chiamvimonvat N Cardiovasc Ther; 2011 Apr; 29(2):99-111. PubMed ID: 20433684 [TBL] [Abstract][Full Text] [Related]
12. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke. Shaik JS; Ahmad M; Li W; Rose ME; Foley LM; Hitchens TK; Graham SH; Hwang SH; Hammock BD; Poloyac SM Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1605-13. PubMed ID: 24043255 [TBL] [Abstract][Full Text] [Related]
13. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Seubert JM; Sinal CJ; Graves J; DeGraff LM; Bradbury JA; Lee CR; Goralski K; Carey MA; Luria A; Newman JW; Hammock BD; Falck JR; Roberts H; Rockman HA; Murphy E; Zeldin DC Circ Res; 2006 Aug; 99(4):442-50. PubMed ID: 16857962 [TBL] [Abstract][Full Text] [Related]